계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Encelle
company
About
Encelle
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $4M
- Industries
- Diabetes,Health Care,Medical
- Founded date
- Jan 1, 2001
- Operating Status
- Active
Encelle, Inc. has developed novel products fortissue regeneration. The company has developed and patented an injectable biopolymer that is expected to have broad application for multiple therapeutic indications. Product development programs are under way in tendo and bone repair, dermal wound repair, cosmetic surgery, and dental applications.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$4M
Encelle has raised a total of
$4M
in funding over 2 rounds. Their latest funding was raised on
Mar 2, 2001 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 2, 2001 | Series Unknown | $4M | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Encelle is funded by 3 investors.
Koerner Capital
and Hibernia Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
|
|
— | Series Unknown |
|
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
